Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran
Behnaz Amernia, Seyed Hamid Moosavy, Fatemeh Banookh, et al.
BMC Gastroenterology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study
Matina Kouvari, Laura Valenzuela‐Vallejo, Valentina Guatibonza-García, et al.
Metabolism (2023) Vol. 147, pp. 155666-155666
Open Access | Times Cited: 47
Effect of different exercise modalities on nonalcoholic fatty liver disease: a systematic review and network meta-analysis
Yaqi Xue, Yang Peng, Litian Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Non-linear relationship between triglyceride glucose index and new-onset diabetes among individuals with non-alcoholic fatty liver disease: a cohort study
Xiaomin Liang, Kai Lai, Xiaohong Li, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Metabolic-Dysfunction-Associated Steatotic Liver Disease: Molecular Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
Jeysson E. Mejía-Guzmán, Ramón A. Belmont-Hernández, Norberto C. Chávez‐Tapia, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2959-2959
Open Access | Times Cited: 1
Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population
Joana Rigor, Andreia Diegues, José Presa, et al.
Postgraduate Medicine (2022) Vol. 134, Iss. 4, pp. 435-440
Closed Access | Times Cited: 29
Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
Laura Valenzuela‐Vallejo, Despina Sanoudou, Christos S. Mantzoros
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 830-830
Open Access | Times Cited: 18
Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants
Sergio M. López Tórrez, Camila Ospina Ayala, Paula Bayer Ruggiro, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 8
Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases
Qichen Chen, Yiqiao Deng, Yuan Li, et al.
Cancer Letters (2024) Vol. 588, pp. 216778-216778
Open Access | Times Cited: 8
Organophosphate pesticide exposure and biomarkers of liver injury/liver function
Wei Li, Haitao Xiao, Hong Wu, et al.
Liver International (2022) Vol. 42, Iss. 12, pp. 2713-2723
Closed Access | Times Cited: 25
Neutrophil to albumin ratio: a biomarker in non-alcoholic fatty liver disease and with liver fibrosis
Banghe Bao, Shuang Xu, Peng Sun, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 6
AST to ALT ratio as a prospective risk predictor for liver cirrhosis in patients with chronic HBV infection
Xiaohuan Lai, Haiyan Chen, Dong Xiao-feng, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 3, pp. 338-344
Open Access | Times Cited: 5
Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
Yijie Li, Brittney O. Baumert, Nikos Stratakis, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 4, pp. 332-345
Open Access | Times Cited: 5
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 8, pp. 798-798
Open Access | Times Cited: 5
Comparison of Guidelines for the Screening, Diagnosis, and Noninvasive Assessment of Nonalcoholic Fatty Liver Disease
Kenneth W. Chow, Pragyat Futela, Aryan Saharan, et al.
Journal of Clinical and Experimental Hepatology (2023) Vol. 13, Iss. 5, pp. 783-793
Open Access | Times Cited: 11
A convenient nomogram for predicting early death or liver transplantation after the Kasai procedure in patients with biliary atresia
Changgui Lu, Hua Xie, Zhongxian Zhu, et al.
Langenbeck s Archives of Surgery (2024) Vol. 409, Iss. 1
Closed Access | Times Cited: 4
Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study
Niloofar Deravi, Fatemeh Dehghani Firouzabadi, Fatemeh Moosaie, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 10
Noninvasive Assessment of the Severity of Liver Fibrosis in MASLD Patients with Long-Standing Type 2 Diabetes
Farooq Ahmad Khan, Stafny Dsouza, Amar Hassan Khamis, et al.
Journal of General Internal Medicine (2025)
Open Access
The Role of Simple and Specialized Non-Invasive Tools in Predicting of Metabolic dysfunction-associated Fatty Liver Disease Severity and Prognosis
Marjan Mokhtare, Shahin Sharafeh, Mohammadjavad Sotoudeheian, et al.
Obesity Medicine (2025), pp. 100582-100582
Closed Access
The effect of calcium and vitamin A in patients with metabolic-associated fatty liver diseases
Reem M. Makbol, Zeinab Mahmoud kadry, Mohamed Mamdouh Noaman, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2025) Vol. 14, Iss. 1
Open Access
Association between cardiovascular health and markers of liver function: a cross-sectional study from NHANES 2005–2018
Yu Huang, Tingyi Zhang, Yankun Liu, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Associations between non-insulin-based insulin resistance surrogate markers and liver-related outcomes in metabolic dysfunction-associated steatotic liver disease: a nationwide cohort study in South Korea
Sang Yi Moon, Minkook Son, Yeo Wool Kang, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
The Effect of Exenatide on Platelets Ratio Index and Fibrosis‐4 Index in Obese Patients With Diabetes Mellitus
Gamze Ergün Sezer, Meral Mert
International Journal of Endocrinology (2025) Vol. 2025, Iss. 1
Open Access
Codonopsis pilosula polysaccharides attenuate lipid accumulation and inflammatory response in the NAFLD mouse by regulating AMPK/ACC/SREBP1 signaling pathway
Chen Qiu, Lin Hai, Xiaodong Huang, et al.
Tissue and Cell (2025), pp. 102984-102984
Closed Access
AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran
Seyed Hamid Moosavy, Ebrahim Eftekhar, Parivash Davoodian, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 9
TyG-GGT is a Reliable Non-Invasive Predictor of Advanced Liver Fibrosis in Overweight or Obese Individuals
LJ Jin, Jing Gu, Zhe Zhang, et al.
Obesity Surgery (2024) Vol. 34, Iss. 4, pp. 1333-1342
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top